To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594
Clinical trial NCT01636024 · COMPLETED
Trial details
- NCT number
- NCT01636024
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.